0.025CAD
−39.48 KCAD
16.51 MCAD
115.92 M
About MICROBIX BIOSYSTEMS
Sector
Industry
CEO
Cameron L. Groome
Website
Headquarters
Mississauga
Founded
1988
ISIN
CA59501P1045
FIGI
BBG000CB00R1
Microbix Biosystems, Inc. engages in developing and commercializing proprietary biological and technology solutions for human health and wellbeing. It operates through the Antigens, QAPs and DxTM, and Other segments. The Antigens, QAPs and DxTM segment includes the development, manufacturing and sales of products relating to the medical diagnostics industry. Other deals with the development and commercialization of novel and proprietary products or technologies such as Kinlytic. The company was founded by William J. Gastle in 1988 and is headquartered in Mississauga, Canada.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of MBX is 0.355 CAD — it has increased by 1.43% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TSX exchange MICROBIX BIOSYSTEMS stocks are traded under the ticker MBX.
MICROBIX BIOSYSTEMS is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
MBX stock is 1.41% volatile and has beta coefficient of −0.09. Check out the list of the most volatile stocks — is MICROBIX BIOSYSTEMS there?
One year price forecast for MICROBIX BIOSYSTEMS has a max estimate of 0.800 CAD and a min estimate of 0.800 CAD.
MICROBIX BIOSYSTEMS revenue for the last quarter amounts to 4.26 M CAD despite the estimated figure of 4.80 M CAD. In the next quarter revenue is expected to reach 8.10 M CAD.
Yes, you can track MICROBIX BIOSYSTEMS financials in yearly and quarterly reports right on TradingView.
MBX stock has fallen by 2.74% compared to the previous week, the month change is a 5.33% fall, over the last year MICROBIX BIOSYSTEMS has showed a 10.13% decrease.
MBX net income for the last quarter is 2.46 M CAD, while the quarter before that showed 2.00 M CAD of net income which accounts for 22.94% change. Track more MICROBIX BIOSYSTEMS financial stats to get the full picture.
Today MICROBIX BIOSYSTEMS has the market capitalization of 48.48 M, it has increased by 1.35% over the last week.
No, MBX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, MBX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MICROBIX BIOSYSTEMS stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MICROBIX BIOSYSTEMS technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MICROBIX BIOSYSTEMS stock shows the sell signal. See more of MICROBIX BIOSYSTEMS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on MICROBIX BIOSYSTEMS future price: according to them, MBX price has a max estimate of 0.80 CAD and a min estimate of 0.80 CAD. Read a more detailed MICROBIX BIOSYSTEMS forecast: see what analysts think of MICROBIX BIOSYSTEMS and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MICROBIX BIOSYSTEMS EBITDA is 2.33 M CAD, and current EBITDA margin is −9.56%. See more stats in MICROBIX BIOSYSTEMS financial statements.